Dynavax Technologies
DVAX
#5495
Rank
โ‚ฌ1.09 B
Marketcap
9,35ย โ‚ฌ
Share price
-0.64%
Change (1 day)
-22.83%
Change (1 year)

Dynavax Technologies (DVAX) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : โ‚ฌ0.35 Billion

According to Dynavax Technologies 's latest financial reports the company's total liabilities are โ‚ฌ0.35 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Dynavax Technologies - Total liabilities on balance sheet (from 2003 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31โ‚ฌ0.37 B10.32%
2023-12-31โ‚ฌ0.33 B-10.11%
2022-12-31โ‚ฌ0.37 B-47.68%
2021-12-31โ‚ฌ0.72 B201.17%
2020-12-31โ‚ฌ0.23 B-0.92%
2019-12-31โ‚ฌ0.24 B87.07%
2018-12-31โ‚ฌ0.12 B705.97%
2017-12-31โ‚ฌ16.03 M-17.66%
2016-12-31โ‚ฌ19.46 M-27.97%
2015-12-31โ‚ฌ27.02 M-13.05%
2014-12-31โ‚ฌ31.08 M134.24%
2013-12-31โ‚ฌ13.27 M-29.57%
2012-12-31โ‚ฌ18.84 M-28.49%
2011-12-31โ‚ฌ26.35 M9.07%
2010-12-31โ‚ฌ24.16 M-21.49%
2009-12-31โ‚ฌ30.77 M-42.22%
2008-12-31โ‚ฌ53.26 M-4.36%
2007-12-31โ‚ฌ55.69 M208.54%
2006-12-31โ‚ฌ18.05 M273.18%
2005-12-31โ‚ฌ4.83 M-52.35%
2004-12-31โ‚ฌ10.15 M-85.61%
2003-12-31โ‚ฌ70.51 M-16.09%
2002-12-31โ‚ฌ84.03 M49.83%
2001-12-31โ‚ฌ56.08 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Agenus
AGEN
โ‚ฌ0.44 B 24.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
โ‚ฌ9.44 B 2,567.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚ฌ66.68 B 18,727.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
โ‚ฌ31.84 B 8,891.24%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚ฌ58.82 B 16,507.74%๐Ÿ‡ฌ๐Ÿ‡ง UK
GlaxoSmithKline
GSK
โ‚ฌ52.63 B 14,761.58%๐Ÿ‡ฌ๐Ÿ‡ง UK
Pfizer
PFE
โ‚ฌ99.31 B 27,941.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
โ‚ฌ28.00 B 7,806.05%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Amgen
AMGN
โ‚ฌ69.16 B 19,426.73%๐Ÿ‡บ๐Ÿ‡ธ USA